Skin-directed therapies are any therapies that are applied or work externally on the skin. Examples of skin-directed treatments for cutaneous lymphomas include topical medications like topical steroids, phototherapy (light therapy), and radiation therapy. Because skin-directed therapies are mostly active on the surface of the skin, without much absorption into the bloodstream, they often have minimal side effects. Patients can often use skin-directed therapies for a long time. Skin-directed therapies are used alone or in combination for treating early stage mycosis fungoides, and are also used in combination with systemic therapies for more advanced disease. Many skin-directed therapies have significant impact on itching and the appearance of cutaneous lymphomas.
Topical corticosteroids (sometimes referred to simply as steroids) are one of the most established treatments for CTCL. Topical steroids have anti-inflammatory effects and directly kill lymphoma cells. There are many options for topical steroids, and multiple formulations are available including creams, gels, ointments, and lotions. They can be very helpful in alleviating symptoms of itching.
Steroids are associated with several side effects such as thinning of the skin (atrophy), which can look like stretch marks or striae, acne/pimples, and hair growth. When topical steroids are applied over a large surface area for a prolonged time they can decrease the activity of the adrenal glands. For these reasons, even though they are generally very safe medications, topical steroid therapy use should be monitored cutaneous lymphoma provider.
Topical chemotherapy agents act by chemically modifying DNA and preventing cancer cells from growing. Mechlorethamine (Mustargen® and Valchlor™), commonly known as nitrogen mustard, and carmustine (BiCNU®) are examples of these. Recently, a gel form of mechlorethamine (Valchlor™) has become available for treatment of CTCL. Although these chemotherapy agents can be toxic when given internally, they are generally very safe when applied topically as the absorption into the bloodstream is very minimal.
There can be side effects from topical chemotherapy. Common side effects are redness, irritation, and/or allergy (dermatitis), development of fine, dilated blood vessels (telangiectasias), or darkening of the skin (hyperpigmentation) in the treated areas.
Retinoids are medications derived from vitamin A, and regulate a wide range of biological processes, including cell growth and death. Retinoids are available as topical or oral formulations. Examples of retinoids include bexarotene (Targretin®), acitretin, and tazarotene gel (Tazorac®). Retinoids have been shown to be effective at killing cancer cells and may actually protect against some types of cancer. Topical bexarotene is approved by the US Food and Drug Administration (FDA) for the treatment of Stage 1A and 1B CTCL in patients who have not responded to or tolerated other therapies. There are also oral forms available (see Systemic Therapies).
Common side effects from topical retinoids, including topical bexarotene, include skin irritation, redness, itching and burning. Skin treated with topical retinoids should be protected from prolonged exposure to sunlight or other sources of ultraviolet (UV) light, such as tanning lamps.
Radiation therapy is considered the most effective single treatment for primary cutaneous lymphoma. Advances in radiation therapy have led to the use of low-energy orthovoltage X-rays and electron beam radiotherapy which, when administered properly, effectively treat the skin without damaging the underlying tissues, such as blood vessels, muscles, and bone marrow. Local radiation therapy is typically used for patients with limited extent tumors (T3) with or without patches and/or plaques, and can provide immense relief for bothersome lesions.
Total Skin Electron Beam
Total skin electron beam (TSEB) therapy is a type of radiation therapy that has shown high response rates, particularly in early-stage disease. This treatment penetrates only the superficial portions of the skin, limiting damage to underlying tissues. Although the treatment is usually very effective, many patients get their disease back slowly over time.
TSEB is a complicated treatment that requires a skilled multidisciplinary team of oncologists, physicists, radiographers, nurses, and dermatologists experienced in the management of cutaneous lymphoma. There are also risks including infection, blisters, skin discoloration, and pain. TSEB therapy can be used on its own or as part of a protocol for stem cell transplantation.